Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
Yusuf
Y
Yazici
Doruk
D
Erkan
Stephen A
SA
Paget
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000517:prevention & control; D016903:Drug Monitoring; D006782:Hospitals, Special; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000191:economics / Q000379:methods* / Q000639:trends
D018501:Antirheumatic Agents; D008727:Methotrexate